FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2969326359> ?p ?o ?g. }

• W2969326359 endingPage "510" @default.
• W2969326359 startingPage "510" @default.
• W2969326359 abstract "Background and objectives: Recurrence of venous thromboembolism (VTE) after a primary event is common; however, no sufficient risk scores have been widely introduced in clinical practice. The aim of this study was to assess the risk factors for VTE recurrences, as well as the effect of treatment strategies on the recurrence rate in a single-center patient cohort. Materials and Methods: The prospective cohort study included consecutive patients in a single center from June 2014 till June 2018 presenting with acute VTE confirmed by imaging tests. All patients were followed up for at least one year or till death. Statistical analyses were conducted using IBM SPSS Statistics 23 and Stata 13. Competing risk of death was considered. Results: A total of 219 eligible patients were identified during the study period. Pulmonary embolism with or without deep vein thrombosis (DVT) was present in 95.9% (n = 210), isolated DVT was present in 4.1% (n = 9) of patients. The total number of documented recurrences was 13 (5.9%). Incidence rate was 5.6 per 100 person-years. Recurrent VTE predicted significantly higher mortality rate (hazard ratio (HR) 6.64 [95% CI 2.61–16.93]). In univariate analysis, active cancer was associated with higher recurrence rate (p = 0.036). In competing-risks regression model (with death as the competing risk), active cancer (subdistribution hazard ratio (SHR) 2.11 (95% CI 0.58–7.76)) did not retain statistical significance for VTE recurrence. Discontinuation and duration of anticoagulant treatment (≤6 or >6 months), and drug class in acute or long-term therapy (parenteral, vitamin K antagonist (VKA), direct oral anticoagulant (DOAC)) were not associated with recurrences (p > 0.05). Conclusions: Patients who experienced recurrent VTE had 6.6-fold higher mortality rate than patients with no recurrences. The presence of active cancer was not a statistically significant risk factor for recurrence when taking into account the competing risk of death. Duration and drug class of anticoagulation did not seem to impact recurrence rate." @default.
• W2969326359 created "2019-08-29" @default.
• W2969326359 creator A5004999025 @default.
• W2969326359 creator A5011158511 @default.
• W2969326359 creator A5016151873 @default.
• W2969326359 creator A5025295225 @default.
• W2969326359 creator A5027189314 @default.
• W2969326359 creator A5035058039 @default.
• W2969326359 creator A5038262994 @default.
• W2969326359 creator A5056360100 @default.
• W2969326359 creator A5070447398 @default.
• W2969326359 date "2019-08-21" @default.
• W2969326359 modified "2023-10-01" @default.
• W2969326359 title "Venous Thromboembolism Recurrence in Latvian Population: Single University Hospital Data" @default.
• W2969326359 cites W1524501969 @default.
• W2969326359 cites W2003601153 @default.
• W2969326359 cites W2007547403 @default.
• W2969326359 cites W2036441262 @default.
• W2969326359 cites W2073715302 @default.
• W2969326359 cites W2082352444 @default.
• W2969326359 cites W2113530759 @default.
• W2969326359 cites W2130199362 @default.
• W2969326359 cites W2134430286 @default.
• W2969326359 cites W2168248028 @default.
• W2969326359 cites W2171381436 @default.
• W2969326359 cites W2225937646 @default.
• W2969326359 cites W2336061167 @default.
• W2969326359 cites W2919328417 @default.
• W2969326359 cites W2950933541 @default.
• W2969326359 doi "https://doi.org/10.3390/medicina55090510" @default.
• W2969326359 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6780231" @default.
• W2969326359 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31438542" @default.
• W2969326359 hasPublicationYear "2019" @default.
• W2969326359 type Work @default.
• W2969326359 sameAs 2969326359 @default.
• W2969326359 citedByCount "2" @default.
• W2969326359 countsByYear W29693263592022 @default.
• W2969326359 countsByYear W29693263592023 @default.
• W2969326359 crossrefType "journal-article" @default.
• W2969326359 hasAuthorship W2969326359A5004999025 @default.
• W2969326359 hasAuthorship W2969326359A5011158511 @default.
• W2969326359 hasAuthorship W2969326359A5016151873 @default.
• W2969326359 hasAuthorship W2969326359A5025295225 @default.
• W2969326359 hasAuthorship W2969326359A5027189314 @default.
• W2969326359 hasAuthorship W2969326359A5035058039 @default.
• W2969326359 hasAuthorship W2969326359A5038262994 @default.
• W2969326359 hasAuthorship W2969326359A5056360100 @default.
• W2969326359 hasAuthorship W2969326359A5070447398 @default.
• W2969326359 hasBestOaLocation W29693263591 @default.
• W2969326359 hasConcept C126322002 @default.
• W2969326359 hasConcept C141071460 @default.
• W2969326359 hasConcept C188816634 @default.
• W2969326359 hasConcept C207103383 @default.
• W2969326359 hasConcept C2776265017 @default.
• W2969326359 hasConcept C2778715236 @default.
• W2969326359 hasConcept C2778959117 @default.
• W2969326359 hasConcept C2780011451 @default.
• W2969326359 hasConcept C2780868729 @default.
• W2969326359 hasConcept C2908647359 @default.
• W2969326359 hasConcept C44249647 @default.
• W2969326359 hasConcept C50382708 @default.
• W2969326359 hasConcept C71924100 @default.
• W2969326359 hasConcept C72563966 @default.
• W2969326359 hasConcept C99454951 @default.
• W2969326359 hasConceptScore W2969326359C126322002 @default.
• W2969326359 hasConceptScore W2969326359C141071460 @default.
• W2969326359 hasConceptScore W2969326359C188816634 @default.
• W2969326359 hasConceptScore W2969326359C207103383 @default.
• W2969326359 hasConceptScore W2969326359C2776265017 @default.
• W2969326359 hasConceptScore W2969326359C2778715236 @default.
• W2969326359 hasConceptScore W2969326359C2778959117 @default.
• W2969326359 hasConceptScore W2969326359C2780011451 @default.
• W2969326359 hasConceptScore W2969326359C2780868729 @default.
• W2969326359 hasConceptScore W2969326359C2908647359 @default.
• W2969326359 hasConceptScore W2969326359C44249647 @default.
• W2969326359 hasConceptScore W2969326359C50382708 @default.
• W2969326359 hasConceptScore W2969326359C71924100 @default.
• W2969326359 hasConceptScore W2969326359C72563966 @default.
• W2969326359 hasConceptScore W2969326359C99454951 @default.
• W2969326359 hasIssue "9" @default.
• W2969326359 hasLocation W29693263591 @default.
• W2969326359 hasLocation W29693263592 @default.
• W2969326359 hasLocation W29693263593 @default.
• W2969326359 hasLocation W29693263594 @default.
• W2969326359 hasOpenAccess W2969326359 @default.
• W2969326359 hasPrimaryLocation W29693263591 @default.
• W2969326359 hasRelatedWork W1988855938 @default.
• W2969326359 hasRelatedWork W2010347505 @default.
• W2969326359 hasRelatedWork W2074708727 @default.
• W2969326359 hasRelatedWork W2171652010 @default.
• W2969326359 hasRelatedWork W2463152737 @default.
• W2969326359 hasRelatedWork W2981730791 @default.
• W2969326359 hasRelatedWork W2999314198 @default.
• W2969326359 hasRelatedWork W3022042949 @default.
• W2969326359 hasRelatedWork W4290193190 @default.
• W2969326359 hasRelatedWork W1603374058 @default.
• W2969326359 hasVolume "55" @default.
• W2969326359 isParatext "false" @default.

• next